Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 643 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MBX Biosciences, Inc. Common Stock
Market Cap
$2.70B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$2.71B
Operating Margin
10.06%
TTM Avg
14.13%
3Y Avg
15.87%
5Y Avg
13.57%
Market Cap
$2.69B
Operating Margin
11.12%
TTM Avg
10.91%
3Y Avg
6.08%
5Y Avg
-3.97%
Market Cap
$2.69B
Operating Margin
-2.49%
TTM Avg
-0.71%
3Y Avg
2.88%
5Y Avg
6.41%
Market Cap
$2.64B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.61B
Operating Margin
-1002.90%
TTM Avg
-694.90%
3Y Avg
-672.96%
5Y Avg
-448.64%
Market Cap
$2.81B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
Market Cap
$2.88B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBX Biosciences, Inc. Common Stock (MBX) | $2.70B | 0.00% | 0.00% | 0.00% | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.71B | 10.06% | 14.13% | 15.87% | 13.57% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 11.12% | 10.91% | 6.08% | -3.97% |
| Neogen Corporation (NEOG)vs › | $2.69B | -2.49% | -0.71% | 2.88% | 6.41% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -274.57% | -464.41% | -382.79% | -92575.80% |
| AtriCure, Inc. (ATRC)vs › | $2.77B | 2.44% | -4.62% | -7.21% | -5.02% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.61B | -1002.90% | -694.90% | -672.96% | -448.64% |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 12.21% | 13.21% | -4.78% | -42.05% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 0.00% | 0.00% | 0.00% | 0.00% |
| Disc Medicine, Inc. (IRON)vs › | $2.45B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
